Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma

Pancreatic ductal adenocarcinoma (PDA) is a lethal disease with limited response to cytotoxic chemoradiotherapy, as well as newer immunotherapies. The PDA tumor microenvironment contains infiltrating immune ce...

Source: Clinical and Translational Medicine - April 1, 2019 Category: Internal Medicine Authors: S. K. Daniel, K. M. Sullivan, K. P. Labadie and V. G. Pillarisetty Tags: Review Source Type: research